[1]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,31(07):139-140.[doi:10.3969/j.issn.1006-1959.2018.07.047]
　LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(07):139-140.[doi:10.3969/j.issn.1006-1959.2018.07.047]
点击复制

头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年07期
页码:
139-140
栏目:
药物与临床
出版日期:
2018-04-01

文章信息/Info

Title:
Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection
文章编号:
1006-1959（2018）07-0139-02
作者:
柳 梅
辽宁省本溪市第三人民医院药械科，辽宁 本溪 117022
Author(s):
LIU Mei
Department of Pharmacy and Medicine,The Third People's Hospital of Benxi City,Benxi 117022,Liaoning,China
关键词:
头孢哌酮钠舒巴坦钠; 糖尿病; 尿路感染; 不良反应
Keywords:
Key words：Cefoperazone sodium and sulbactam sodium; Diabetes mellitus; Urinary tract infection; Adverse reactions
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2018.07.047
文献标志码:
A
摘要:
目的 观察头孢哌酮钠舒巴坦钠对糖尿病并发尿路感染的治疗效果及不良反应。方法 选取2015年2月~2017年2月本院收治的70例糖尿病并发尿路感染患者，以抽签分组法分为观察组和对照组，每组35例。对照组予以甲磺酸左氧氟沙星治疗，观察组予以头孢哌酮钠舒巴坦钠治疗，比较两组患者的治疗效果和不良反应情况。结果 观察组患者治疗总有效率为94.29%，高于对照组的71.43%，差异具有统计学意义（P＜0.05）。观察组患者不良反应发生率为5.71%，低于对照组的25.71%，差异具有统计学意义（P＜0.05）。结论 头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染，疗效显著，安全性较高，值得借鉴。
Abstract:
Abstract：Objective To observe the efficacy and adverse reactions of cefoperazone sodium and sulbactam sodium in the treatment of diabetes complicated with urinary tract infection.Methods 70 cases of diabetes mellitus complicated with urinary tract infection in our hospital in February 2015~February 2017 were divided into the observation group and the control group,with 35 cases in each group.The control group was given levofloxacin mesylate treatment,observation group was treated with cefoperazone sodium and sulbactam sodium for treatment,compared two groups of curative effects and adverse reactions.Results The total effective rate of treatment in the observation group was 94.29%,which was higher than that of the control group 71.43%,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was 5.71%,which was lower than that of the control group 25.71%,and the difference was statistically significant(P<0.05).Conclusion Cefoperazone sodium and sulbactam sodium in treatment of diabetes complicated with urinary tract infection,curative effect,high safety,worthy of reference.

参考文献/References:

[1]陈锦春.宁泌泰胶囊治疗糖尿病尿路感染的临床疗效观察[J].北方药学,2015,12(12):14-15. [2]向绪锡.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的疗效及不良反应[J].中国医药指南,2014,12(23):209-210. [3]裴雪萍.头孢哌酮钠舒巴坦钠治疗糖尿病合并尿路感染患者的疗效及安全性分析[J].中国药物经济学,2016,11(05):89-90. [4]黄淑娟.复方石韦片联合左氧氟沙星治疗2型糖尿病合并尿路感染患者的疗效观察[J].当代医学,2016,22(19):118-119. [5]王廷海,付研.维生素C在2型糖尿病合并尿路感染治疗中的疗效观察[J].中国医药导刊,2015,17(03):280-281. [6]厉东亚,孙文强.左氧氟沙星胶囊联合癃清片治疗2型糖尿病合并尿路感染的疗效观察[J].现代药物与临床,2014,29(01):68-70.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
　ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Journal of Medical Information,2018,31(07):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
　GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign Tumor and Diabetic Patients[J].Journal of Medical Information,2018,31(07):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
　LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
　LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
　XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2018,31(07):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
　ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Journal of Medical Information,2018,31(07):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[7]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
　ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Journal of Medical Information,2018,31(07):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[8]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
　LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[9]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
　LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
[10]陈军锋.增生型糖尿病性视网膜病变前后段联合手术的疗效观察[J].医学信息,2018,31(10):99.[doi:10.3969/j.issn.1006-1959.2018.10.030]
　CHEN Jun-feng.Effect of Combined Anterior and Posterior Segment Surgery on Proliferative Diabetic Retinopathy[J].Journal of Medical Information,2018,31(07):99.[doi:10.3969/j.issn.1006-1959.2018.10.030]
[11]魏长斌.头孢哌酮钠舒巴坦钠对糖尿病合并尿路感染的疗效及安全性分析[J].医学信息,2021,34(14):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]
　WEI Chang-bin.Analysis of the Efficacy and Safety of Cefoperazone Sodium and Sulbactam Sodium on Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2021,34(07):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]

更新日期/Last Update: 2018-04-01